Redefining risk of contralateral cervical nodal disease in early stage oropharyngeal cancer in the human papillomavirus era.
Andrew W SmithMatthew GallittoEric J LehrerIsaac WassermanVishal GuptaSonam SharmaJerry T LiuMarshall PosnerKrzysztof MisiukiewiczWilliam H WestraEric M GendenYarah HaidarMike YaoMarita S TengBrett A MilesRichard L BakstPublished in: Head & neck (2021)
HPV-related OPSCC that are cN0-N1 have exceedingly low rates of pCND. Well-lateralized HPV-related BOT primaries with limited clinical nodal disease may be candidates for ipsilateral only treatment.